
Stryker Corporation SYK
$ 285.22
3.54%
Stryker Corporation Accounts Payables | SYK
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.8 B | 1.68 B | 1.52 B | 1.41 B | 1.13 B | 810 M | 675 M | 646 M | 487 M | 437 M | 410 M | 329 M | 314 M | 288 M | 345 M | 292 M | 200 M | 274 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 200 M | 725 M |
Quarterly Accounts Payables Stryker Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.66 B | 1.59 B | 1.5 B | 1.44 B | 1.46 B | 1.34 B | 1.3 B | 1.25 B | 1.3 B | 1.33 B | 1.37 B | 1.41 B | 1.21 B | - | 1.08 B | 1.13 B | 934 M | 864 M | 767 M | 810 M | 810 M | 810 M | 810 M | 675 M | 675 M | 675 M | 675 M | 646 M | 646 M | 646 M | 646 M | 487 M | 487 M | 487 M | 487 M | 437 M | 437 M | 437 M | 437 M | 410 M | 410 M | 410 M | 410 M | 329 M | 329 M | 329 M | 329 M | 314 M | 314 M | 314 M | 314 M | 288 M | 288 M | 288 M | 288 M | 345 M | 345 M | 345 M | 345 M | 248 M | 213 M | 231 M | 204 M | 212 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.66 B | 204 M | 683 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Penumbra
PEN
|
34.7 M | $ 317.11 | 0.07 % | $ 12.3 B | ||
|
Insulet Corporation
PODD
|
75 M | $ 135.62 | 2.98 % | $ 9.54 B | ||
|
Profound Medical Corp.
PROF
|
1.56 M | $ 6.03 | 3.25 % | $ 182 M | ||
|
Quanterix Corporation
QTRX
|
13.6 M | $ 3.81 | 4.67 % | $ 162 M | ||
|
Sintx Technologies
SINT
|
382 K | $ 2.18 | 1.05 % | $ 6.05 M | ||
|
Sensus Healthcare
SRTS
|
1.5 M | $ 2.92 | 0.34 % | $ 47.7 M | ||
|
Tactile Systems Technology
TCMD
|
4.97 M | $ 22.47 | 1.67 % | $ 514 M | ||
|
TELA Bio
TELA
|
2.31 M | $ 1.14 | 0.88 % | $ 53.5 M | ||
|
TransMedics Group
TMDX
|
10.4 M | $ 82.99 | 4.0 % | $ 2.82 B | ||
|
Tandem Diabetes Care
TNDM
|
47.1 M | $ 16.52 | 0.12 % | $ 1.12 B | ||
|
Viemed Healthcare
VMD
|
7.33 M | $ 9.24 | 1.2 % | $ 359 M | ||
|
Varex Imaging Corporation
VREX
|
69.9 M | $ 18.45 | 0.14 % | $ 764 M | ||
|
Vivos Therapeutics
VVOS
|
1.68 M | $ 0.15 | 1.52 % | $ 1.54 M | ||
|
Beyond Air
XAIR
|
2.42 M | $ 2.84 | 0.71 % | $ 23.6 B | ||
|
Xtant Medical Holdings
XTNT
|
3.84 M | $ 0.33 | 0.09 % | $ 46 M | ||
|
Zimmer Biomet Holdings
ZBH
|
303 M | $ 91.57 | 3.72 % | $ 18.1 B | ||
|
Nemaura Medical
NMRD
|
327 K | - | -17.8 % | $ 2.74 M | ||
|
Sientra
SIEN
|
6.82 M | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
5.68 M | - | - | $ 1.07 B | ||
|
Surgalign Holdings
SRGA
|
7.7 M | - | -32.98 % | $ 1.68 M | ||
|
ShockWave Medical
SWAV
|
8.87 M | - | - | $ 12.3 B | ||
|
Natus Medical Incorporated
NTUS
|
36.4 M | - | 1.94 % | $ 1.05 B | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Inari Medical
NARI
|
10.6 M | - | - | $ 4.23 B | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
NuVasive
NUVA
|
20.3 M | - | - | $ 2.07 B | ||
|
Axonics Modulation Technologies
AXNX
|
18.5 M | - | - | $ 3.31 B | ||
|
ThermoGenesis Holdings
THMO
|
948 K | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
1.34 M | - | 3.55 % | $ 7.96 M | ||
|
Viveve Medical
VIVE
|
1.48 M | - | -15.35 % | $ 1.71 M | ||
|
ViewRay
VRAY
|
28.3 M | - | 1.54 % | $ 468 M | ||
|
SmileDirectClub
SDC
|
30.5 M | - | -53.45 % | $ 9.71 M | ||
|
Acutus Medical
AFIB
|
1.28 M | - | -26.83 % | $ 2.62 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Vapotherm
VAPO
|
5.05 M | - | 6.72 % | $ 34 M | ||
|
SeaSpine Holdings Corporation
SPNE
|
20.3 M | - | 0.28 % | $ 270 M | ||
|
Nevro Corp.
NVRO
|
24.5 M | - | - | $ 217 M | ||
|
Abiomed
ABMD
|
35.3 M | - | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Venus Concept
VERO
|
6.48 M | - | - | $ 726 K | ||
|
Zynex
ZYXI
|
2.88 M | - | - | $ 21.1 M | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M |